Clinical Trial

Study on Preliminary Safety and Efficacy of Epidural Electrical Stimulation to Manage Lower Urinary Tract Dysfunction After Spinal Cord Injury

Study acronym: ReeVoid
Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial aims to assess the preliminary safety and efficacy of Epidural Electrical Stimulation (EES) therapy in managing lower urinary tract dysfunction in individuals with sub-acute or chronic spinal cord injury (SCI). The study evaluates the therapy's potential to improve urinary function and prevent neurogenic detrusor overactivity, ultimately seeking to enhance quality of life for individuals with SCI.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-20.
Status change: Not Yet Recruiting → Recruiting 2025-07-09
Trial Details
NCT Number NCT06845904
Lead Sponsor Ecole Polytechnique Fédérale de Lausanne
Conditions Spinal Cord Injuries (SCI), Spinal Cord Injury
Enrollment 3 participants
Start Date 2025-03-10
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-07-14